GR32741B - Μεθοδος παρασκευης νεου αντιβιοτικου. - Google Patents

Μεθοδος παρασκευης νεου αντιβιοτικου.

Info

Publication number
GR32741B
GR32741B GR670132741A GR670132741A GR32741B GR 32741 B GR32741 B GR 32741B GR 670132741 A GR670132741 A GR 670132741A GR 670132741 A GR670132741 A GR 670132741A GR 32741 B GR32741 B GR 32741B
Authority
GR
Greece
Prior art keywords
preparation
new antibiotic
antibiotic
following
chloroform
Prior art date
Application number
GR670132741A
Other languages
English (en)
Original Assignee
Rhone - Poulenc S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone - Poulenc S.A. filed Critical Rhone - Poulenc S.A.
Publication of GR32741B publication Critical patent/GR32741B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

ο αντιβιοτικόν 13.252 R.P., το οποίον έχει τα ακόλουθα χαρακτηριστικά: είναι τούτο κόνις άμορφος, λευκή, λίαν διαλυτή εις τας αλκοόλας μικρού μοριακού βάρους, ως είναι η μεθανόλη και η αιθανόλη, εις τους χλωριωμένους διαλύτας, ως είναι το μεθυλενοχλωρίδιον, το διχλωραιθάνιον, το χλωροφόρμιον, εις τον οξικόν αιθυλαστέρα και εις τον τετραχλωράνθρακα, τον αιθέρα και το ύδωρ και πρακτικώς αδιάλυτον εις το εξάνιον. Περιέχει άνθρακα, υδρογόνον, οξυγόνον και άζωτον και η στοιχειακή του σύνθεσις είναιγειτονική της ακολούθου: C% - 63 H% - 5.95 O% -20,85 N% - 9.90
GR670132741A 1966-04-01 1967-03-31 Μεθοδος παρασκευης νεου αντιβιοτικου. GR32741B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR56121A FR1516743A (fr) 1966-04-01 1966-04-01 Nouvel antibiotique et son procédé de préparation par culture de streptomyces croceus

Publications (1)

Publication Number Publication Date
GR32741B true GR32741B (el) 1967-08-26

Family

ID=8605365

Family Applications (1)

Application Number Title Priority Date Filing Date
GR670132741A GR32741B (el) 1966-04-01 1967-03-31 Μεθοδος παρασκευης νεου αντιβιοτικου.

Country Status (6)

Country Link
AT (1) AT270067B (el)
BE (1) BE696462A (el)
ES (1) ES338783A1 (el)
FR (2) FR1516743A (el)
GR (1) GR32741B (el)
NL (1) NL6703208A (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1813614T1 (sl) 2006-01-25 2012-01-31 Sanofi 174 Citotoksična sredstva, ki obsegajo nove tomajmicinske derivate
ES2673822T3 (es) 2006-07-18 2018-06-25 Sanofi Anticuerpo antagonista contra EphA2 para el tratamiento de cáncer
EP1914242A1 (en) 2006-10-19 2008-04-23 Sanofi-Aventis Novel anti-CD38 antibodies for the treatment of cancer
PL2019104T3 (pl) 2007-07-19 2014-03-31 Sanofi Sa Środki cytotoksyczne obejmujące nowe pochodne tomaymycyny i ich zastosowanie terapeutyczne
FR2949469A1 (fr) 2009-08-25 2011-03-04 Sanofi Aventis Derives anticancereux, leur preparation et leur application en therapeutique
TW201116297A (en) 2009-10-02 2011-05-16 Sanofi Aventis Antibodies that specifically bind to the EphA2 receptor
FR2963007B1 (fr) 2010-07-26 2013-04-05 Sanofi Aventis Derives anticancereux, leur preparation et leur application therapeutique
EP2849753B1 (en) 2012-05-14 2022-08-10 Sanofi Method for producing recombinant 11-de-o-methyltomaymycin
TW201808336A (zh) 2016-05-11 2018-03-16 賽諾菲公司 用抗ｍｕｃ１類美登素免疫綴合物抗體治療腫瘤的治療方案

Also Published As

Publication number Publication date
AT270067B (de) 1969-04-10
BE696462A (el) 1967-10-02
FR1516743A (fr) 1968-02-05
ES338783A1 (es) 1968-04-16
NL6703208A (el) 1967-10-02
FR5764M (el) 1968-02-05

Similar Documents

Publication Publication Date Title
GR32741B (el) Μεθοδος παρασκευης νεου αντιβιοτικου.
ES2052518T3 (es) Agente viricida con efecto de amplio espectro.
GB1181100A (en) Polyoxyperfluoromethylene Compounds
FR2256154A1 (el)
JPS51125144A (en) Stabilized organic materials composition
GB1461062A (en) Oxygenated tricyclic derivatives as perfuming and flavouring agents
GB1241270A (en) Stabilized methyl chloroform composition
SE8501809D0 (sv) Drivmedel
GB1479239A (en) Acylated 2-hydrazono formyl quinoxaline-1,4-dioxides
JPS5241547A (en) Airtight window
GB1159461A (en) Improvements in or relating to Tetrabromobicyclononane and Self-Extinguishing Polymer Compositions derived therefrom
SPINDLER et al. The Chemiluminescent Reaction O+ H â OH+ hν
GB843756A (en) Improvements in and relating to new derivative of isonicotinothioamide
FR2069758A5 (en) 9 alpha -hydroxy-11 beta-nitrato-steroids
GB1414793A (en) Derivatives of phenylaminopyridine
GB961922A (en) Substituted 1,2,4-dioxazines
ES324607A1 (es) Procedimiento para conseguir la estabilizaciën dimensional de la lana
Rench et al. Effect of Composition in Inter-Impurity Radiation Recombination in Germanium--SiliconAlloy
JPS51125152A (en) Photo-setting aqueous composition
Danilov et al. Variation of the ion composition of the atmosphere at heights between 100 and 200 km(Electron and ion concentrations as function of solar radiation intensity and variation of ionospheric conditions, noting nitrous oxide/ oxygen ion ratio)
GB1064312A (en) Halogenated chromanolderivatives
GR23505B (el) Μεθοδος παρασκευης νεου αντιβιοτικου.
JPS5236130A (en) Preparation of copper phthalocyanine
GB1420368A (en) Curable compositions
BATES et al. Electrical conductivity of thorium dioxide(Electrical conductivity of ThO 2 at room and high temperatures and in high intensity gamma radiation fields)